1.Torre LA, Siegel RL, Jemal A. Lung Cancer Statistics. In: Ahmad A, Gadgeel S, editors. Lung Cancer and Personalized Medicine: Current Knowledge and Therapies. Cham: Springer International Publishing; 2016.1-19.
2. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68:394–424.
3. Reck M, Rabe KF. Precision diagnosis and treatment for advanced non-small-cell lung Cancer. N Engl J Med. 2017; 377:849–61.
4. Han B; Li K; Zhao Y; Li B; Cheng Y; Zhou J; Lu Y; Shi Y; Wang Z; Jiang L. et al. Anlotinib as a third-line therapy in patients with refractory advanced non-small-cell lung cancer: a multicentre, randomised phase II trial (ALTER0302). Br J Cancer. 2018; 118:654–61.
5. Ock CY; Park JM; Han YM; Jeong M; Kim MY; Lee HJ; Hahm KB. Genetic ablation or pharmacologic inhibition of autophagy mitigated NSAID-associated gastric damages. J Mol Med (Berl). 2017;95:405-416.
6. Wang H, Wang L, Cao L, Zhang Q, Song Q, Meng Z, Wu X; Xu K. Inhibition of autophagy potentiates the anti-metastasis effect of phenethyl isothiocyanate through JAK2/STAT3 pathway in lung cancer cells. Mol Carcinog. 2018; 57:522–35.
7. Li NP, Li WD, Song DD, Rong JJ, Qian AM, Li XQ. Metformin inhibits endothelial progenitor cell migration by decreasing matrix metalloproteinases, MMP-2 and MMP-9, via the AMPK/mTOR/autophagy pathway.Int J Mol Med. 2017;39:1262–8.
8. Zhu M, Wang S, Wang Q, Hou Y, Li L, Weng H, Zhao Y, Chen D, Guo J, Ding H, Li M. Publisher Correction: Alpha-fetoprotein inhibits autophagy to promote malignant behaviour in hepatocellular carcinoma cells by activating PI3K/AKT/mTOR signalling. Cell Death Dis. 2019;10:214.
9. Pei X, Guo Y. Tetrandrine-induced autophagy in MDA-MB-231 triple-negative breast cancer cell through the inhibition of PI3K/AKT/mTOR signaling. Evid Based Complement Altern Med.2019; 2019:7517431.
10. Signore M, Ricci-Vitiani L, De Maria R. Targeting apoptosis pathways in cancer stem cells. Cancer Lett. 2013; 332:374-82.
11. Mori M, Hitora T, Nakamura O, Yamagami Y, Horie R, Nishimura H, Yamamoto T. Hsp90
inhibitor induces autophagy and apoptosis in osteosarcoma cells. Int J Oncol. 2015; 46:47-54.
12. Moon HJ, Kim HB, Lee SH, Jeun SE, Kang CD, Kim SH. Sensitization of multidrug-resistant cancer cells to Hsp90 inhibitors by NSAIDs-induced apoptotic and autophagic cell death. Oncotarget 2018; 9:11303-21.
13. Choudhury S, Kolukula VK, Preet A, Albanese C, Avantaggiati ML. Dissecting the pathways that destabilize mutant p53 The proteasome or autophagy? Cell Cycle 2013; 12:1022-29.
14. Zhang YJ; Bao YJ; Dai Q; Yang WY; Cheng P; Zhu LM; Wang BJ; Jiang FH. mTOR Signaling is Involved in Indomethacin and Nimesulide Suppression of Colorectal Cancer Cell Growth via a COX-2 Independent Pathway. Ann Surg Oncol. 2011; 18:580–588.
15. Tomoko Katoa; Hiromichi Fujino; Satomi Oyama; Tatsuo Kawashima; Toshihiko Murayama. Indomethacin induces cellular morphological change and migration via epithelial-mesenchymal transition in A549 human lung cancer cells: A novel cyclooxygenase-inhibition-independent effect. Biochemical Pharmacology.2011;82:1781-1791.
16. Ulrich CM, Bigler J, Potter JD. Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics. Nat Rev Cancer 2006; 6:130–40.
17. Nazim, U.M., Moon, J.H., Lee, Y.J., Seol, J.W., Park, S.Y., PPAR activation by troglitazone enhances human lung cancer cells to TRAIL-induced apoptosis via autophagic flux. Oncotarget. 2017; 8:26819-26831.
18. Yan, S., Yang, X., Chen, T., Xi, Z., Jiang, X., The PPAR agonist troglitazone induces autophagy, apoptosis and necroptosis in bladder cancer cells. Cancer Gene Ther. 2014; 21:188-193.
19. Wang F; Xia X ; Yang C; Shen J; Mai J; Kim HC; Kirui D; Kang Y; Fleming JB; Koay EJ .et al. SMAD4 Gene Mutation Renders Pancreatic Cancer Resistance to Radiotherapy through Promotion of Autophagy. Clin Cancer Res. 2018; 24:3176-3185.
20. Wang Z; Guo J; Han X; Xue M; Wang W; Mi L; Sheng Y; Ma C; Wu J; Wu X. Metformin represses the pathophysiology of AAA by suppressing the activation of PI3K/AKT/mTOR/autophagy pathway in ApoE-/- mice. Cell Biosci. 2019; 27;9:68.
21. Lange A 1, Gustke H, Glassmeier G, Heine M, Zangemeister-Wittke U, Schwarz JR, Schumacher U, Lange T. Neuronal differentiation by indomethacin and IBMX inhibits proliferation of small cell lung cancer cells in vitro. Lung Cancer. 201;74:178-87.
22. Harada S; Nakagawa T; Yokoe S; Edogawa S; Takeuchi T; Inoue T; Higuchi K; Asahi M.
Autophagy Deficiency Diminishes Indomethacin-Induced Intestinal Epithelial Cell Damage through Activation of the ERK/Nrf2/HO-1 Pathway. J Pharmacol Exp Ther. 2015; 355:353-61.
23. Yang N, Qu YJ, Cheng Y, et al. Endoplasmic reticulum stress regulates proliferation, migration and invasion of human ovarian cancer SKOV3 cells through PI3K/AKT/mTOR signaling pathway. Cancer Biomark.2017;19:263–269.
24. Hyun-Jung Moon, So-Young Park, Su-Hoon Lee, Chi-Dug Kang, Sun-Hee Kim. Non-steroidal anti-inflammatory drugs sensitize CD44-overexpressing cancer cells to Hsp90 inhibitor through autophagy activation. Oncology Research.2019;27:835-847.
25. Liang LJ; Hui KY; Hu CX; Wen YX; Yang SK; Zhu PR; Wang L; Xia YY; Qiao Y; Sun W. Autophagy inhibition potentiates the anti-angiogenic property of multikinase inhibitor anlotinib through JAK2/STAT3/VEGFA signaling in non-small cell lung cancer cells. Journal of Experimental & Clinical Cancer Research.2019;38:71.
26. Chandrika G, Natesh K, Ranade D, Chugh A, Shastry P. Suppression of the invasive potential of glioblastoma cells by mTOR inhibitors involves modulation of NFκB and PKC-α signaling. Sci Rep. 2016; 6:22455.